Literature DB >> 17342651

Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.

Simona Bratu1, Steven Brooks, Sibte Burney, Sandeep Kochar, Jyoti Gupta, David Landman, John Quale.   

Abstract

A carbapenem-resistant isolate of Escherichia coli was identified that possessed a 23-kb plasmid encoding Klebsiella pneumoniae carbapenemase type 2 (KPC-2). A subsequent surveillance study involving hospitals in Brooklyn, New York, revealed that, among 1417 E. coli isolates, 7 isolates (from 3 hospitals) possessed bla(KPC-2). E. coli possessing KPC-2 is emerging in our region, and improved methods for detection are urgently needed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17342651     DOI： 10.1086/512370

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  44 in total

1.  Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Authors:  David Landman; Carl Urban; Martin Bäcker; Paul Kelly; Neha Shah; Elizabeth Babu; Simona Bratu; John Quale
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.

Authors:  Gaelle Cuzon; Thierry Naas; Marie Claude Demachy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

3.  Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.

Authors:  Jonas Marschall; Robert J Tibbetts; W Michael Dunne; Jonathan G Frye; Victoria J Fraser; David K Warren
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

4.  Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Zmira Samra; Judi Bahar; Liora Madar-Shapiro; Nazi Aziz; Sara Israel; Jihad Bishara
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

5.  First outbreak of KPC-3-producing Klebsiella pneumoniae (ST258) clinical isolates in a Mexican Medical Center.

Authors:  Patricia Rodríguez-Zulueta; Jesús Silva-Sánchez; Humberto Barrios; Javier Reyes-Mar; Francisco Vélez-Pérez; Sara Arroyo-Escalante; Luis Ochoa-Carrera; Gabriela Delgado-Sapien; María Del Rosario Morales-Espinoza; Elsa Tamayo-Legorreta; Rigoberto Hernández-Castro; Ulises Garza-Ramos
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

6.  Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.

Authors:  Jia Chang Cai; Rong Zhang; Yan Yan Hu; Hong Wei Zhou; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

Review 7.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.

Authors:  Felipe Francisco Tuon; Jaime L Rocha; Marcelo R Formigoni-Pinto
Journal:  Infection       Date:  2017-11-07       Impact factor: 3.553

9.  Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.

Authors:  Ping Shen; Zeqing Wei; Yan Jiang; Xiaoxing Du; Shujuan Ji; Yunsong Yu; Lanjuan Li
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

10.  Escherichia coli and Klebsiella pneumoniae carbapenemase in long-term care facility, Illinois, USA.

Authors:  Marcella McGuinn; Ronald C Hershow; William M Janda
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.